Victory Capital Management Inc. Has $6.44 Million Position in DaVita Inc. (NYSE:DVA)

Victory Capital Management Inc. lowered its holdings in shares of DaVita Inc. (NYSE:DVA) by 56.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,263 shares of the company’s stock after selling 51,093 shares during the period. Victory Capital Management Inc.’s holdings in DaVita were worth $6,436,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Transcendent Capital Group LLC acquired a new stake in DaVita during the third quarter worth $25,000. Blue Trust Inc. boosted its stake in DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new stake in DaVita during the second quarter worth $43,000. Versant Capital Management Inc boosted its stake in DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after buying an additional 155 shares in the last quarter. Finally, Friedenthal Financial acquired a new stake in DaVita during the second quarter worth $48,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Bank of America lifted their price objective on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. UBS Group lifted their price objective on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Barclays lifted their price objective on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. Finally, Truist Financial lifted their price objective on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat, DaVita presently has an average rating of “Hold” and a consensus price target of $161.80.

Insider Activity at DaVita

In other DaVita news, CFO Joel Ackerman sold 64,029 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the completion of the sale, the chief financial officer now directly owns 111,481 shares of the company’s stock, valued at approximately $17,286,243.86. The trade was a 36.48 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Javier Rodriguez sold 50,000 shares of the business’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total value of $8,252,500.00. Following the sale, the chief executive officer now directly owns 837,835 shares of the company’s stock, valued at $138,284,666.75. This represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 156,086 shares of company stock valued at $24,807,161 over the last ninety days. 2.00% of the stock is owned by insiders.

DaVita Stock Performance

DaVita stock opened at $165.51 on Friday. The stock has a 50-day simple moving average of $158.31 and a 200 day simple moving average of $148.29. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. DaVita Inc. has a 12-month low of $98.26 and a 12-month high of $168.50. The stock has a market capitalization of $13.57 billion, a price-to-earnings ratio of 17.85, a P/E/G ratio of 0.89 and a beta of 0.89.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the firm earned $2.85 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, research analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.